Picod, Adrien
Azibani, Feriel
Harjola, Veli-Pekka
Karakas, Mahir
Kimmoun, Antoine
Levy, Bruno
Pickkers, Peter
Thiele, Holger
Zeymer, Uwe
Santos, Karine
Mebazaa, Alexandre
Article History
Received: 15 June 2025
Accepted: 5 July 2025
First Online: 31 July 2025
Declarations
:
: Not applicable.
: Not applicable.
: AP reports having received research grants from the Société de Réanimation de Langue Française (SRLF), the Société Française d’Anesthésie Réanimation (SFAR), the Zoll Fondation, the Fonds pour la chirurgie cardiaque and 4TEEN4 Pharmaceuticals GmbH. MK is supported by the Else Kroener-Fresenius-Stiftung (W3 Else Kroener Clinician Scientist Professorship). He reports grant and non-financial support from Adrenomed AG and CSL Vifor, as well as personal fees from Adrenomed AG, Sphingotec GmbH, CSL Vifor, Daiichi-Sankyo, Pharmacosmos and 4TEEN4 Pharmaceuticals GmbH. PP has received research grants, travel and consultancy reimbursements from 4TEEN4 Pharmaceuticals GmbH. UZ received speaker honoraria form 4TEEN4 Pharmaceuticals. KS is employed as chief scientific officer at 4TEEN4 Pharmaceuticals GmbH. AM reports personal fees from Orion, Roche, Adrenomed and Fire 1, and grants and personal fees from 4TEEN4 Pharmaceuticals GmbH, Abbott, Roche, and Sphingotec GmbH.